Form 4: Lilly Endowment Sells Shares in Eli Lilly & Co

Lilly Endowment Inc. sold a total of 49,760 shares of Eli Lilly & Co. common stock on May 23, 2024, at various prices.

Summary

• Lilly Endowment Inc., a significant shareholder of Eli Lilly & Co., sold 49,760 shares of common stock on May 23, 2024.
• The sales were executed in multiple transactions throughout the day at prices ranging from $804.00 to $820.50 per share.
• The weighted average prices for each block of sales are detailed in the document.
• Following these transactions, Lilly Endowment Inc. still holds a substantial 98,648,810 shares of Eli Lilly & Co. common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of a stock sale, which is neither positive nor negative in itself. It reflects normal market activity.

Management Comments

• Peter A. Buck, Vice President for Investments and Grants Administration, signed the Form 4 on behalf of Lilly Endowment Inc.

Industry Context

This is a routine filing for a significant shareholder disclosing a sale of shares, which is common in the market. It does not indicate any specific trend in the pharmaceutical industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership by insiders and large shareholders in publicly traded companies.
• The transactions are typical for large institutional investors managing their portfolios.
• The sale of 49,760 shares is a relatively small portion of Lilly Endowment's total holdings of 98,648,810 shares, suggesting a minor portfolio adjustment rather than a significant change in investment strategy.

Stakeholder Impact

• The sale of shares may have a minor impact on the stock price of Eli Lilly & Co., but the overall impact is likely to be minimal given the relatively small volume of shares sold compared to the total outstanding shares.
• The transaction does not directly impact employees, customers, or suppliers.

Key Dates

Keywords

Eli Lilly & Co, Lilly Endowment Inc, stock sale, share transaction, beneficial ownership, Form 4